Ranked by engagement
Top topics — all time page 5
Ranked by replies, likes and views over all time, with a bonus for topics that reached a marked solution. Engagement is a proxy for usefulness and a poor one; the documentation commons is the better index of what is settled.
1,535 topics · page 5 of 40
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Follow-up: Search filters: what is missing
On the subject in the title: Search filters: what is missing Working notes rather than a conclusion. Nominating something for promotion into the documentation commons. The topic in question keeps being…
|
+126 | 141 | 1.6k | 29d |
|
Second pass at: Hoarding and why it makes a shortage worse
Second pass at: Hoarding and why it makes a shortage worse Writing it up because I had to work it out twice and would rather nobody else did. Documenting an access outcome, dated, because everything in this…
|
+115 | 133 | 11k | 21mo |
|
Which panel is worth repeating and which is worth ignoring
The question in the title: Which panel is worth repeating and which is worth ignoring I will give what I have already checked below so nobody repeats it. General question, not a request for advice about my…
|
+125 | 133 | 17k | 10mo |
|
Reading an interaction checker output critically
On the subject in the title: Reading an interaction checker output critically Working notes rather than a conclusion. I have read the maintained page on this and I still have a gap, so I am asking rather than…
|
+144 | 152 | 3k | 4mo |
|
Counter-ion content and its effect on measured mass
On the subject in the title: Counter-ion content and its effect on measured mass Working notes rather than a conclusion. Working through the identity arithmetic and I would like it checked. retatrutide has a…
|
+100 | 108 | 45k | 12mo |
|
Converting between mg/mL and units per dose, both directions
Posting this under the heading it deserves: Converting between mg/mL and units per dose, both directions Everything below is what sits behind that. Practical question with the units stated, because I have…
|
+106 | 142 | 9.5k | 19mo |
|
What a certificate commits its issuer to
The question in the title: What a certificate commits its issuer to I will give what I have already checked below so nobody repeats it. A documentation question rather than an analytical one. I have a…
|
+101 | 116 | 26k | 19h |
|
Cost per milligram, computed honestly across formats — the long version
Cost per milligram, computed honestly across formats — the long version Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork detail…
|
+111 | 124 | 24k | 14mo |
|
Carryover and the ghost peak from last week's standard — what changed since
Carryover and the ghost peak from last week's standard — what changed since Writing it up because I had to work it out twice and would rather nobody else did. Posting the method first, because I know what the…
|
+98 | 114 | 37k | 22d |
|
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one I have a specific reason for asking rather than idle curiosity, and the context is below. Comparing SURPASS-4 ( Lancet , 2021)…
|
+130 | 135 | 11k | 7mo |
|
Semaglutide half-life: where the 165 to 184 hour figure comes from
Semaglutide half-life: where the 165 to 184 hour figure comes from — setting out what I have, and where I think it stops being reliable. Comparing FLOW ( N Engl J Med , 2024) with STEP 4 ( JAMA , 2021) and…
|
+128 | 145 | 3k | 4mo |
|
[2026 update] A vial that will not fully dissolve: what to check and in what order
Posting this under the heading it deserves: A vial that will not fully dissolve: what to check and in what order Everything below is what sits behind that. Practical question with the units stated, because I…
|
+114 | 128 | 20k | 1mo |
|
Journal club: SUSTAIN 6 and its retinopathy signal
On the subject in the title: Journal club: SUSTAIN 6 and its retinopathy signal Working notes rather than a conclusion. I have seen SELECT ( N Engl J Med , 2023) cited in support of a claim I do not think it…
|
+110 | 122 | 46k | 1d |
|
Why we ask for units every single time, with three examples of what goes wrong
Why we ask for units every single time, with three examples of what goes wrong — that is the question, and I have not found it answered plainly anywhere I have looked. Question in the title. Context below,…
|
+118 | 135 | 2.2k | 11d |
|
Journal club: what we got wrong in an earlier session
On the subject in the title: Journal club: what we got wrong in an earlier session Working notes rather than a conclusion. Session topic: SURMOUNT-1 ( N Engl J Med , 2022). Please read it before posting; the…
|
+114 | 125 | 2.5k | 23h |
|
Run-in periods and the population they select
On the subject in the title: Run-in periods and the population they select Working notes rather than a conclusion. Session topic: PIONEER 6 ( N Engl J Med , 2019). Please read it before posting; the…
|
+130 | 142 | 7.3k | 1mo |
|
Building a sensible monitoring schedule with your prescriber
Building a sensible monitoring schedule with your prescriber — setting out what I have, and where I think it stops being reliable. General question, not a request for advice about my own care — I know the…
|
+91 | 108 | 52k | 19mo |
|
Coming back to: Why a preprint's supplementary material is often the best part
Why a preprint's supplementary material is often the best part — that is the question, and I have not found it answered plainly anywhere I have looked. Comparing SURPASS-2 ( N Engl J Med , 2021) with STEP 4 (…
|
+109 | 116 | 36k | 2d |
|
Coming back to: Why quantitation is the hard part, not detection
Why quantitation is the hard part, not detection — that is the question, and I have not found it answered plainly anywhere I have looked. Posting the method first, because I know what the first three replies…
|
+86 | 92 | 54k | 8mo |
|
Revisiting: The best-written scientific paper you have read
Posting this under the heading it deserves: Revisiting: The best-written scientific paper you have read Everything below is what sits behind that. Lower-stakes topic, but the sourcing rule still applies if…
|
+102 | 121 | 21k | 1h |
|
Revisiting: Reading a denial letter as a specification for your appeal
Posting this under the heading it deserves: Revisiting: Reading a denial letter as a specification for your appeal Everything below is what sits behind that. A coverage question with the paperwork detail…
|
+125 | 138 | 9.4k | 10mo |
|
Follow-up: Why appetite effects are mostly central
Asking directly, because I could not find a straight answer: Why appetite effects are mostly central A documentation question rather than an analytical one. I have a certificate in front of me that reports a…
|
+86 | 90 | 61k | 9mo |
|
Journal club: STEP 1 and the treatment-policy estimand — does this still hold?
Asking directly, because I could not find a straight answer: Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Comparing STEP 2 ( Lancet , 2021) with SURMOUNT-4 ( JAMA , 2024) and…
|
+118 | 132 | 12k | 15mo |
|
Reading a supplier's product description as a marketing document
On the subject in the title: Reading a supplier's product description as a marketing document Working notes rather than a conclusion. I have seen PIONEER 6 ( N Engl J Med , 2019) cited in support of a claim I…
|
+86 | 97 | 62k | 8mo |
|
What SELECT changed about how semaglutide is discussed, and what it did not
Asking directly, because I could not find a straight answer: What SELECT changed about how semaglutide is discussed, and what it did not Session topic: SURMOUNT-1 ( N Engl J Med , 2022). Please read it before…
|
+120 | 132 | 2k | 14mo |
|
Which panel is worth repeating and which is worth ignoring — a second dataset
Asking directly, because I could not find a straight answer: Which panel is worth repeating and which is worth ignoring — a second dataset General question, not a request for advice about my own care — I know…
|
+108 | 117 | 46k | 4mo |
|
Request: a per-category review queue
Request: a per-category review queue Writing it up because I had to work it out twice and would rather nobody else did. Nominating something for promotion into the documentation commons. The topic in question…
|
+125 | 136 | 13k | 2h |
|
Guidelines revision: what changed and why
Guidelines revision: what changed and why Writing it up because I had to work it out twice and would rather nobody else did. Process question about how this site works. I have read the guidelines and the…
|
+127 | 142 | 1.7k | 2y |
|
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Writing it up because I had to work it out twice and would rather nobody else did. Session topic: SURMOUNT-OSA ( N Engl J Med ,…
|
+81 | 90 | 54k | 9mo |
|
[2026 update] Journal club: is percentage weight change the right endpoint?
Journal club: is percentage weight change the right endpoint? — that is the question, and I have not found it answered plainly anywhere I have looked. Comparing SURPASS-2 ( N Engl J Med , 2021) with…
|
+105 | 118 | 18k | 11mo |